statistiche ricercatore

Nazione	#
US - Stati Uniti d'America	508
SG - Singapore	169
IT - Italia	86
VN - Vietnam	83
CN - Cina	82
BR - Brasile	61
IE - Irlanda	41
SE - Svezia	40
HK - Hong Kong	38
DE - Germania	26
ZA - Sudafrica	20
FR - Francia	17
NL - Olanda	17
GB - Regno Unito	14
IN - India	12
CA - Canada	10
FI - Finlandia	9
JP - Giappone	6
MX - Messico	6
ES - Italia	5
TR - Turchia	5
AR - Argentina	4
AT - Austria	4
BD - Bangladesh	4
CI - Costa d'Avorio	4
CL - Cile	4
MY - Malesia	4
PA - Panama	4
PH - Filippine	4
PK - Pakistan	4
RU - Federazione Russa	4
EC - Ecuador	3
EG - Egitto	3
ID - Indonesia	3
SA - Arabia Saudita	3
TH - Thailandia	3
VE - Venezuela	3
JO - Giordania	2
LT - Lituania	2
MA - Marocco	2
PL - Polonia	2
BB - Barbados	1
BE - Belgio	1
BG - Bulgaria	1
BO - Bolivia	1
CR - Costa Rica	1
CZ - Repubblica Ceca	1
DK - Danimarca	1
GE - Georgia	1
GR - Grecia	1
HR - Croazia	1
IQ - Iraq	1
IR - Iran	1
KR - Corea	1
MM - Myanmar	1
NP - Nepal	1
PE - Perù	1
PS - Palestinian Territory	1
PT - Portogallo	1
QA - Qatar	1
RO - Romania	1
SK - Slovacchia (Repubblica Slovacca)	1
TT - Trinidad e Tobago	1
UA - Ucraina	1
UZ - Uzbekistan	1
Totale	1.345

Nome	#
Chest x-ray or CT for COVID-19 pneumonia? Comparative study in a simulated triage setting	217
COVID-19 in Children: Update on Diagnosis and Management	146
Structural changes in lung morphology detected by MRI after modulating therapy with elexacaftor/tezacaftor/ivacaftor in adolescent and adult patients with cystic fibrosis	134
Renal artery embolization of non-functioning graft: an effective treatment for graft intolerance syndrome	129
Clinical Impact of Aspergillus fumigatus in Children with Cystic Fibrosis	126
Validation by CT scan of quadriceps muscle thickness measurement by ultrasound in acute kidney injury	123
The impact of muscle mass and myosteatosis on mortality in critically ill patients with Sars-Cov2-related pneumonia	108
Detection and Classification of Bronchiectasis through Convolutional Neural Networks	107
Imaging in non-cystic fibrosis bronchiectasis and current limitations	106
Effect of elexacaftor-tezacaftor-ivacaftor modulator on lung structure in cystic fibrosis	73
The Trajectories of Neuromuscular Aging (TRAJECTOR-AGE Clinical Trial): Study Rationale and Methodological Protocol	71
Effect of elexacaftor-tezacaftor-ivacaftor modulator on lung structure in cystic fibrosis	21
Totale	1.361

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2020/2021	18	0	0	0	0	0	0	0	0	0	10	4	4
2021/2022	47	2	1	6	2	2	3	8	4	2	0	1	16
2022/2023	182	18	23	13	22	18	16	1	13	48	1	4	5
2023/2024	90	8	7	3	4	1	20	17	4	6	3	9	8
2024/2025	268	8	11	29	22	25	23	16	12	30	23	29	40
2025/2026	734	65	44	109	70	102	59	68	35	111	71	0	0
Totale													1.361